[IOICORP] QoQ TTM Result on 30-Sep-2022 [#1]

Announcement Date
25-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2023
Quarter
30-Sep-2022 [#1]
Profit Trend
QoQ- -6.38%
YoY- 15.87%
Quarter Report
View:
Show?
TTM Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 11,583,800 13,369,200 14,806,700 15,615,000 15,578,700 15,302,300 14,064,500 -12.16%
PBT 1,526,000 2,091,300 2,411,400 2,220,900 2,352,600 2,167,900 2,062,900 -18.25%
Tax -396,000 -451,700 -551,900 -568,700 -583,700 -581,000 -494,700 -13.82%
NP 1,130,000 1,639,600 1,859,500 1,652,200 1,768,900 1,586,900 1,568,200 -19.67%
-
NP to SH 1,114,200 1,618,800 1,832,600 1,615,200 1,725,300 1,542,900 1,533,000 -19.20%
-
Tax Rate 25.95% 21.60% 22.89% 25.61% 24.81% 26.80% 23.98% -
Total Cost 10,453,800 11,729,600 12,947,200 13,962,800 13,809,800 13,715,400 12,496,300 -11.24%
-
Net Worth 11,357,163 11,111,424 11,237,384 10,685,328 10,934,879 10,375,709 10,326,859 6.56%
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div 682,815 869,550 869,550 870,300 870,300 748,939 748,939 -5.99%
Div Payout % 61.28% 53.72% 47.45% 53.88% 50.44% 48.54% 48.85% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth 11,357,163 11,111,424 11,237,384 10,685,328 10,934,879 10,375,709 10,326,859 6.56%
NOSH 6,258,100 6,258,100 6,258,100 6,258,100 6,258,100 6,258,100 6,258,100 0.00%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 9.76% 12.26% 12.56% 10.58% 11.35% 10.37% 11.15% -
ROE 9.81% 14.57% 16.31% 15.12% 15.78% 14.87% 14.84% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 186.65 215.37 238.49 251.35 250.74 246.29 226.08 -12.02%
EPS 17.95 26.08 29.52 26.00 27.77 24.83 24.64 -19.08%
DPS 11.00 14.00 14.00 14.00 14.00 12.00 12.00 -5.65%
NAPS 1.83 1.79 1.81 1.72 1.76 1.67 1.66 6.73%
Adjusted Per Share Value based on latest NOSH - 6,258,100
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 185.10 213.63 236.60 249.52 248.94 244.52 224.74 -12.16%
EPS 17.80 25.87 29.28 25.81 27.57 24.65 24.50 -19.23%
DPS 10.91 13.89 13.89 13.91 13.91 11.97 11.97 -6.01%
NAPS 1.8148 1.7755 1.7957 1.7074 1.7473 1.658 1.6502 6.56%
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 3.73 3.81 4.05 3.77 3.84 4.12 3.73 -
P/RPS 2.00 1.77 1.70 1.50 1.53 1.67 1.65 13.72%
P/EPS 20.78 14.61 13.72 14.50 13.83 16.59 15.14 23.57%
EY 4.81 6.84 7.29 6.90 7.23 6.03 6.61 -19.14%
DY 2.95 3.67 3.46 3.71 3.65 2.91 3.22 -5.68%
P/NAPS 2.04 2.13 2.24 2.19 2.18 2.47 2.25 -6.34%
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 22/08/23 30/05/23 28/02/23 25/11/22 23/08/22 20/05/22 23/02/22 -
Price 4.05 3.91 3.83 3.98 4.19 4.40 4.42 -
P/RPS 2.17 1.82 1.61 1.58 1.67 1.79 1.96 7.04%
P/EPS 22.56 14.99 12.98 15.31 15.09 17.72 17.94 16.55%
EY 4.43 6.67 7.71 6.53 6.63 5.64 5.58 -14.29%
DY 2.72 3.58 3.66 3.52 3.34 2.73 2.71 0.24%
P/NAPS 2.21 2.18 2.12 2.31 2.38 2.63 2.66 -11.65%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment